NCT05159388
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05159388
Title A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pieris Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | BEL | AUS

Facility Status City State Zip Country Details
Carolina Bio Oncology Huntersville North Carolina 28078 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Cabrini Oncology Research Malvern Victoria Australia Details
Chris O'Brian Lifehouse Camperdown Australia Details
The Queen Elizabeth Hospital Woodville South Australia Details
Institute Jules Bordet Brussels Belgium Details
Universitair Ziekenhuis Edegem Belgium Details
U.Z. Gent Medical Oncology Ghent Belgium Details
Hospital Vall d'Hebron Barcelona Spain Details
START Madrid 28050 Spain Details
Hospital Universitario Gregorio Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field